a public good project by the
Synthesis
Company
of California

© 2026

Yoshimi Iwayama | doi.page

0 works0 citations0 h-index

Yoshimi Iwayama

Kobe Pharmaceutical University(JP)

Publications by Year

Research Areas

Genetics and Neurodevelopmental Disorders, Autism Spectrum Disorder Research, Genetic Associations and Epidemiology, Bipolar Disorder and Treatment, Proteoglycans and glycosaminoglycans research

Most-Cited Works

→ Sintered carbonate apatites as bioresorbable bone substitutes(1998)236 cited
→ Fabp7 Maps to a Quantitative Trait Locus for a Schizophrenia Endophenotype(2007)218 cited
→ Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients(2007)217 cited
→ Osteoclastic responses to various calcium phosphates in cell cultures(1999)188 cited
→ Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect(2018)164 cited
→ Enhanced Carbonyl Stress in a Subpopulation of Schizophrenia(2010)162 cited

→ Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3 , as potential susceptibility candidates in schizophrenia(2007)

161 cited

→ Genome-wide expression analysis detects eight genes with robust alterations specific to bipolar I disorder: relevance to neuronal network perturbation(2006)148 cited

→ Brain region-specific altered expression and association of mitochondria-related genes in autism(2012)147 cited

→ Genome‐wide Association Study of Autism Spectrum Disorder in the East Asian Populations(2015)118 cited